These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 36078409)

  • 1. Latent Tuberculosis Infection in Haematopoietic Stem Cell Transplant Recipients: A Retrospective Italian Cohort Study in Tor Vergata University Hospital, Rome.
    Compagno M; Navarra A; Campogiani L; Coppola L; Rossi B; Iannetta M; Malagnino V; Parisi SG; Mariotti B; Cerretti R; Arcese W; Goletti D; Andreoni M; Sarmati L
    Int J Environ Res Public Health; 2022 Aug; 19(17):. PubMed ID: 36078409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Host factors associated to false negative and indeterminate results in an interferon-γ release assay in patients with active tuberculosis.
    Santos JA; Duarte R; Nunes C
    Pulmonology; 2020; 26(6):353-362. PubMed ID: 31843341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of a heparin-binding haemagglutinin interferon-gamma release assay to the detection of Mycobacterium tuberculosis infection in HIV-infected patients: comparison with the tuberculin skin test and the QuantiFERON-TB Gold In-tube.
    Wyndham-Thomas C; Dirix V; Schepers K; Martin C; Hildebrand M; Goffard JC; Domont F; Libin M; Loyens M; Locht C; Van Vooren JP; Mascart F
    BMC Infect Dis; 2015 Feb; 15():59. PubMed ID: 25886172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interferon-γ release assay as a sensitive diagnostic tool of latent tuberculosis infection in patients with HIV: a cross-sectional study.
    Klautau GB; da Mota NVF; Salles MJC; Burattini MN; Rodrigues DS
    BMC Infect Dis; 2018 Nov; 18(1):585. PubMed ID: 30453903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent and active tuberculosis infection in allogeneic hematopoietic stem cell transplant recipients: a prospective cohort study.
    de Oliveira Rodrigues M; de Almeida Testa LH; Dos Santos ACF; Zanetti LP; da Silva Ruiz L; de Souza MP; Colturato VR; Machado CM
    Bone Marrow Transplant; 2021 Sep; 56(9):2241-2247. PubMed ID: 33966056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chest roentgenography is complementary to interferon-gamma release assay in latent tuberculosis infection screening of rheumatic patients.
    Wang PH; Lin CH; Chang TH; Wu CS
    BMC Pulm Med; 2020 Aug; 20(1):232. PubMed ID: 32867745
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculin skin testing and treatment modulates interferon-gamma release assay results for latent tuberculosis in migrants.
    O'Shea MK; Fletcher TE; Beeching NJ; Dedicoat M; Spence D; McShane H; Cunningham AF; Wilson D
    PLoS One; 2014; 9(5):e97366. PubMed ID: 24816576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Latent Tuberculosis Infection Diagnosis among Household Contacts in a High Tuberculosis-Burden Area: a Comparison between Transcript Signature and Interferon Gamma Release Assay.
    Kaul S; Nair V; Birla S; Dhawan S; Rathore S; Khanna V; Lohiya S; Ali S; Mannan S; Rade K; Malhotra P; Gupta D; Khanna A; Mohmmed A
    Microbiol Spectr; 2022 Apr; 10(2):e0244521. PubMed ID: 35416716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of Mycobacterium tuberculosis infection as measured by the QuantiFERON-TB Gold assay and ESAT-6 free IGRA among adolescents in Mwanza, Tanzania.
    Jeremiah K; Lyimo E; Ritz C; PrayGod G; Rutkowski KT; Korsholm KS; Ruhwald M; Tait D; Grewal HMS; Faurholt-Jepsen D
    PLoS One; 2021; 16(6):e0252808. PubMed ID: 34097715
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk Groups of Developing Active Tuberculosis in Liver Transplant Recipients in a Tuberculosis Endemic Area: Risk Stratification by Chest Image and Interferon Gamma Release Assay.
    Kim SH; Oh S; Nham E; Ko JH; Huh K; Cho SY; Kang CI; Chung DR; Choi GS; Kim JM; Joh JW; Peck KR
    Int J Infect Dis; 2021 Dec; 113():359-366. PubMed ID: 34718154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordance between TST and QFT-TBGold Plus for Latent Tuberculosis Screening among Under-Five Children: An Interim Analysis.
    Surve S; Bhor V; Naukariya K; Begum S; Munne K; Tipre P; Sutar N; Jaiswal A; Bhonde G; Chauhan S; Shah I
    J Trop Pediatr; 2021 Dec; 67(6):. PubMed ID: 34904674
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis infection screening in children with close contact: a hospital-based study.
    Sun L; Qi X; Guo Y; Qi H; Li J; Wu X; Yin Q; Guo Y; Xu B; Wang Y; Jin Q; Gao L; Shen A
    BMC Infect Dis; 2021 Aug; 21(1):815. PubMed ID: 34388985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of an interferon-gamma release assay to screen for pediatric latent tuberculosis infection in the eastern region of the Emirate of Abu Dhabi.
    Al Mekaini LA; Al Jabri ON; Narchi H; Kamal SM; Mabrook A; Al Kuwaiti MM; Sheek-Hussein MM; Souid AK; Alsuwaidi AR
    Int J Infect Dis; 2014 Jun; 23():4-7. PubMed ID: 24657274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparing interferon-gamma release assays with tuberculin skin test for identifying latent tuberculosis infection that progresses to active tuberculosis: systematic review and meta-analysis.
    Auguste P; Tsertsvadze A; Pink J; Court R; McCarthy N; Sutcliffe P; Clarke A
    BMC Infect Dis; 2017 Mar; 17(1):200. PubMed ID: 28274215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic potential of interferon-gamma release assay to detect latent tuberculosis infection in kidney transplant recipients.
    Edathodu J; Varghese B; Alrajhi AA; Shoukri M; Nazmi A; Elgamal H; Aleid H; Alrabiah F; Ashraff A; Mahmoud I; Al-Hajoj S
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28170135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis progression rates in U.S. Immigrants following screening with interferon-gamma release assays.
    Blount RJ; Tran MC; Everett CK; Cattamanchi A; Metcalfe JZ; Connor D; Miller CR; Grinsdale J; Higashi J; Nahid P
    BMC Public Health; 2016 Aug; 16(1):875. PubMed ID: 27558397
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of interferon-gamma release assay for screening and monitoring of latent tuberculosis infection in kidney transplant recipients.
    Bruminhent J; Treekajonsak T; Kantachuvesiri S; Setthaudom C; Sukkasem W; Kawamatawong T
    BMC Infect Dis; 2024 Oct; 24(1):1110. PubMed ID: 39375585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined IFN-γ and TNF-α release assay for differentiating active tuberculosis from latent tuberculosis infection.
    Kim JY; Park JH; Kim MC; Cha HH; Jeon NY; Park SY; Kim MJ; Chong YP; Lee SO; Choi SH; Kim YS; Woo JH; Kim SH
    J Infect; 2018 Oct; 77(4):314-320. PubMed ID: 29746954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of Latent Tuberculosis Infection Based on the Interferon-γ Release Assay in Allogeneic Stem Cell Transplant Recipients.
    Park JH; Choi EJ; Park HS; Choi SH; Lee SO; Kim YS; Woo JH; Lee JH; Lee JH; Lee KH; Shim TS; Kim SH
    Clin Infect Dis; 2020 Nov; 71(8):1977-1979. PubMed ID: 31930297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
    Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
    Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.